• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高初级保健中对支气管扩张症的认识:成人诊断和管理策略概述。

Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults.

机构信息

Scottish Centre for Respiratory Research, University of Dundee, Dundee, UK.

University at Buffalo, State University of New York, Buffalo, NY, USA.

出版信息

NPJ Prim Care Respir Med. 2017 Mar 13;27(1):18. doi: 10.1038/s41533-017-0019-9.

DOI:10.1038/s41533-017-0019-9
PMID:28270656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5434781/
Abstract

Bronchiectasis is a chronic lung disease characterised by recurrent infection, inflammation, persistent cough and sputum production. The disease is increasing in prevalence, requiring a greater awareness of the disease across primary and secondary care. Mild and moderate cases of bronchiectasis in adults can often be managed by primary care clinicians. Initial assessments and long-term treatment plans that include both pharmacological and non-pharmacological treatments, however, should be undertaken in collaboration with a secondary care team that includes physiotherapists and specialists in respiratory medicine. Bronchiectasis is often identified in patients with other lung diseases, such as chronic obstructive pulmonary disease, asthma, and in a lesser but not insignificant number of patients with other inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease. Overall goals of therapy are to prevent exacerbations, improve symptoms, improve quality of life and preserve lung function. Prompt treatment of exacerbations with antibiotic therapy is important to limit the impact of exacerbations on quality of life and lung function decline. Patient education and cooperation with health-care providers to implement treatment plans are key to successful disease management. It is important for the primary care provider to work with secondary care providers to develop an individualised treatment plan to optimise care with the goal to delay disease progression. Here, we review the diagnosis and treatment of bronchiectasis with a focus on practical considerations that will be useful to primary care.

摘要

支气管扩张症是一种慢性肺部疾病,其特征为反复感染、炎症、持续咳嗽和咳痰。该病的患病率在增加,这就要求初级和二级保健都要提高对该病的认识。轻度和中度的成人支气管扩张症通常可以由初级保健临床医生进行管理。然而,初始评估和包括药物和非药物治疗在内的长期治疗计划应由包括物理治疗师和呼吸医学专家在内的二级保健团队共同制定。支气管扩张症通常在患有其他肺部疾病的患者中发现,例如慢性阻塞性肺疾病、哮喘,在数量较少但并非微不足道的患有其他炎症性疾病的患者中也发现,例如类风湿关节炎和炎症性肠病。治疗的总体目标是预防恶化、改善症状、提高生活质量和保护肺功能。及时用抗生素治疗恶化对限制恶化对生活质量和肺功能下降的影响很重要。患者教育和与医疗保健提供者合作实施治疗计划是成功管理疾病的关键。初级保健提供者与二级保健提供者合作制定个体化治疗计划以优化护理并延缓疾病进展非常重要。在这里,我们重点讨论支气管扩张症的诊断和治疗,其中包含对初级保健有用的实用注意事项。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/5434781/bfa375744c9c/41533_2017_19_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/5434781/4dfe18ceeb0b/41533_2017_19_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/5434781/2e87c4aae710/41533_2017_19_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/5434781/7155bdabebbf/41533_2017_19_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/5434781/bfa375744c9c/41533_2017_19_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/5434781/4dfe18ceeb0b/41533_2017_19_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/5434781/2e87c4aae710/41533_2017_19_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/5434781/7155bdabebbf/41533_2017_19_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afc/5434781/bfa375744c9c/41533_2017_19_Fig4_HTML.jpg

相似文献

1
Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults.提高初级保健中对支气管扩张症的认识:成人诊断和管理策略概述。
NPJ Prim Care Respir Med. 2017 Mar 13;27(1):18. doi: 10.1038/s41533-017-0019-9.
2
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
3
Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.因非囊性纤维化相关性支气管扩张感染加重而住院的患者:临床、生理及痰液特征
Respirology. 2017 Jul;22(5):922-927. doi: 10.1111/resp.13005. Epub 2017 Feb 24.
4
Update in Bronchiectasis 2014.2014年支气管扩张症最新进展
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1155-61. doi: 10.1164/rccm.201505-0926UP.
5
Bronchiectasis: an update.支气管扩张症:最新进展
Clin Respir J. 2009 Jul;3(3):126-34. doi: 10.1111/j.1752-699X.2009.00131.x.
6
Paediatric and adult bronchiectasis: Specific management with coexisting asthma, COPD, rheumatological disease and inflammatory bowel disease.儿童和成人支气管扩张症:伴发哮喘、COPD、风湿性疾病和炎症性肠病的具体管理。
Respirology. 2019 Nov;24(11):1063-1072. doi: 10.1111/resp.13615. Epub 2019 Jun 20.
7
Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis.支气管扩张症中双重支气管扩张剂研究(DIBS):一项实用的、多中心、安慰剂对照、三臂、双盲、随机对照试验方案,研究支气管扩张剂预防支气管扩张症恶化。
BMJ Open. 2023 Aug 10;13(8):e071906. doi: 10.1136/bmjopen-2023-071906.
8
Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?澳大利亚三级护理中支气管扩张症成人患者的管理:基于证据还是以获取为导向?
Lung. 2019 Dec;197(6):803-810. doi: 10.1007/s00408-019-00280-x. Epub 2019 Nov 5.
9
COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.COPD-X 澳大利亚和新西兰慢性阻塞性肺疾病诊断和管理指南:2017 年更新版。
Med J Aust. 2017 Nov 20;207(10):436-442. doi: 10.5694/mja17.00686.
10
Bronchiectasis.支气管扩张症。
Nat Rev Dis Primers. 2018 Nov 15;4(1):45. doi: 10.1038/s41572-018-0042-3.

引用本文的文献

1
Machine learning using genotype and gene-expression data identifies alterations of genes involved in infection susceptibility, antigen presentation and cytokine signalling as key contributors to JIA risk prediction.利用基因型和基因表达数据的机器学习识别出参与感染易感性、抗原呈递和细胞因子信号传导的基因改变,这些是幼年特发性关节炎风险预测的关键因素。
RMD Open. 2025 Jul 9;11(3):e005737. doi: 10.1136/rmdopen-2025-005737.
2
Current status of pharmacists in community pharmacies in China in the health management of chronic respiratory diseases.中国社区药房药师在慢性呼吸道疾病健康管理中的现状
BMC Public Health. 2025 Mar 18;25(1):1052. doi: 10.1186/s12889-025-22272-8.
3

本文引用的文献

1
Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.支气管扩张症的多维严重程度评估:对七个欧洲队列的分析
Thorax. 2016 Dec;71(12):1110-1118. doi: 10.1136/thoraxjnl-2016-208481. Epub 2016 Aug 11.
2
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.实施抗生素管理计划:美国传染病学会和美国医疗保健流行病学学会指南
Clin Infect Dis. 2016 May 15;62(10):e51-77. doi: 10.1093/cid/ciw118. Epub 2016 Apr 13.
3
Chronic cough and a normal chest X-ray - a simple systematic approach to exclude common causes before referral to secondary care: a retrospective cohort study.
Nontuberculous mycobacterial pulmonary disease (NTM PD) incidence trends in the United States, 2010-2019.
美国非结核分枝杆菌性肺病(NTM PD)发病率趋势,2010-2019 年。
BMC Infect Dis. 2024 Oct 2;24(1):1094. doi: 10.1186/s12879-024-09965-y.
4
New-onset obstructive airway disease following COVID-19: a multicenter retrospective cohort study.新型冠状病毒病后新发阻塞性气道疾病:一项多中心回顾性队列研究。
BMC Med. 2024 Sep 4;22(1):360. doi: 10.1186/s12916-024-03589-4.
5
Supporting Patients with Nontuberculous Mycobacterial Pulmonary Disease: Ensuring Best Practice in UK Healthcare Settings.支持非结核分枝杆菌肺病患者:确保英国医疗环境中的最佳实践。
Pharmacy (Basel). 2024 Aug 21;12(4):126. doi: 10.3390/pharmacy12040126.
6
Effects of Probiotics on Clinical Manifestations of Bronchiectasis: A Randomized, Triple Blinded, Placebo-Controlled Clinical Trial.益生菌对支气管扩张症临床表现的影响:一项随机、三盲、安慰剂对照临床试验
Tanaffos. 2023 Feb;22(2):221-229.
7
Microbiology sampling in non-cystic fibrosis bronchiectasis cases from northern Alberta.阿尔伯塔省北部非囊性纤维化支气管扩张症病例的微生物采样。
PLoS One. 2023 Jul 14;18(7):e0288704. doi: 10.1371/journal.pone.0288704. eCollection 2023.
8
Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals.非转诊医院应用宏基因组下一代测序技术快速诊断非结核分枝杆菌肺病。
Front Cell Infect Microbiol. 2023 Jan 24;12:1083497. doi: 10.3389/fcimb.2022.1083497. eCollection 2022.
9
Mutagenic damage among bronchiectasis patients attending in the pulmonology sector of a hospital in southern Brazil.巴西南部一家医院肺病科就诊的支气管扩张症患者中的诱变损伤。
Rev Assoc Med Bras (1992). 2022 Sep;68(9):1191-1198. doi: 10.1590/1806-9282.20220178.
10
Non-pharmacological Management of Non-productive Chronic Cough in Adults: A Systematic Review.成人非特异性慢性咳嗽的非药物治疗:一项系统评价
Front Rehabil Sci. 2022 May 26;3:905257. doi: 10.3389/fresc.2022.905257. eCollection 2022.
慢性咳嗽且胸部 X 线正常 - 在转诊至二级保健之前排除常见病因的简单系统方法:一项回顾性队列研究。
NPJ Prim Care Respir Med. 2016 Mar 3;26:15081. doi: 10.1038/npjpcrm.2015.81.
4
The dangers of widespread nitric oxide screening for primary ciliary dyskinesia.广泛进行原发性纤毛运动障碍的一氧化氮筛查的危害。
Thorax. 2016 Jun;71(6):560-1. doi: 10.1136/thoraxjnl-2015-208056. Epub 2016 Feb 19.
5
Clinical phenotypes in adult patients with bronchiectasis.支气管扩张症成年患者的临床表型。
Eur Respir J. 2016 Apr;47(4):1113-22. doi: 10.1183/13993003.01899-2015. Epub 2016 Feb 4.
6
The bronchiectasis severity index and FACED score for bronchiectasis.支气管扩张严重程度指数及支气管扩张的FACED评分
Eur Respir J. 2016 Feb;47(2):382-4. doi: 10.1183/13993003.01717-2015.
7
Primary ciliary dyskinesia in adults.成人原发性纤毛运动障碍
Rev Mal Respir. 2016 Feb;33(2):165-89. doi: 10.1016/j.rmr.2015.10.743. Epub 2015 Dec 1.
8
Efficiency and safety of surgical intervention to patients with Non-Cystic Fibrosis bronchiectasis: a meta-analysis.非囊性纤维化支气管扩张症患者手术干预的有效性和安全性:一项荟萃分析。
Sci Rep. 2015 Dec 2;5:17382. doi: 10.1038/srep17382.
9
Surgical treatment of bronchiectasis: A review of 20 years of experience.支气管扩张症的外科治疗:20年经验回顾
Rev Port Pneumol (2006). 2016 Mar-Apr;22(2):82-5. doi: 10.1016/j.rppnen.2015.09.007. Epub 2015 Nov 10.
10
Bronchiectasis is increasing in the UK, study shows.研究显示,支气管扩张症在英国正呈上升趋势。
BMJ. 2015 Nov 4;351:h5916. doi: 10.1136/bmj.h5916.